Galectin Therapeutics (GALT) Other Non-Current Assets (2010 - 2026)

Galectin Therapeutics' Other Non-Current Assets history runs 14 years deep, the most recent figure standing at $68000.0 for Q1 2026.

• In Q1 2026, Other Non-Current Assets fell 72.02% year-over-year to $68000.0; the TTM figure through Mar 2026 stood at $68000.0 (down 72.02% YoY), while the FY2025 annual figure was $96000.0, down 60.49% from the prior year.
• Other Non-Current Assets was $68000.0 for Q1 2026 at Galectin Therapeutics, down from $96000.0 in the prior quarter.
• In the past five years, Other Non-Current Assets ranged from a high of $793000.0 in Q3 2022 to a low of $68000.0 in Q1 2026.
• Historically, Other Non-Current Assets has averaged $360470.6 across 5 years, with a median of $306000.0 in 2024.
• The sharpest annual moves came in 2022 and 2026: Other Non-Current Assets jumped 10371.43% in 2022, then sank 72.02% in 2026.
• A 5-year view of Other Non-Current Assets shows it stood at $733000.0 in 2022, then sank by 33.15% to $490000.0 in 2023, then sank by 50.41% to $243000.0 in 2024, then sank by 60.49% to $96000.0 in 2025, then fell by 29.17% to $68000.0 in 2026.
• The last three Other Non-Current Assets figures came in at $68000.0 (Q1 2026), $96000.0 (Q4 2025), and $136000.0 (Q3 2025), per Business Quant data.